Narrow Results

Circulating tumor cells (CTCs) are malignant cells that are derived from a solid tumor in the metastasis stage and are shed into the blood stream. These cells hold great promise to be used as liquid biopsy that is less aggressive than traditional biopsy. Recently, detection and enumeration of these cells has received ever-increasing attention from researchers as a way of early detection of cancer metastasis, determining the effectiveness of treatment and studying the mechanism of formation of secondary tumors. CTCs are found in blood at low concentration, which is a major limitation of isolation and detection of these cells. Over the last few years, multifarious research studies have been conducted on accurate isolation and detection and post processing of CTCs. Among all the proposed systems, microfluidic systems seem to be more attractive for researchers due to their numerous advantages. On the other hand, recent developments in optical methods have made the possibility of cellular studies at single-cell level. Thus, accuracy and efficiency of separation, detection and manipulation of CTCs can be improved using optical techniques. In this review, we describe optical methods that have been used for CTC detection, manipulation and post processing.

APTAR PHARMA Provides Unit-Dose Nasal Spray Technology for Treatment of Opioid Overdose

Cloudera, Broad Institute Collaborate on the Next Generation of the Genome Analysis Toolkit

Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group

FEI Launches Apreo – Industry-Leading Versatile, High-Performance SEM

BOGE Publishes New Guide on Specifying Compressed Air for Healthcare

Takara Bio USA, Inc. and Integrated DNA Technologies Announce Collaboration to Support Targeted RNA Sequencing

Pelican BioThermal Announces Launch of New Asia Headquarters in Singapore

A Faster Way to Separate Proteins with Electrophoresis

Biosensors Announces Strategic Agreement with Cardinal Health

BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine

CSI: Cancer Scene Investigation

Improving risk stratification in hypertensive heart disease: What is in the horizon?

NRGene delivers first-ever food potato genomes.

CMC Biologics announces development and manufacturing agreement with Harpoon Therapeutics.

Typhoid vaccine prequalified.

Clearbridge BioMedics’ ClearCell FX1 system achieves U.S. FDA listing.

Singapore eDevelopment names Dr Roscoe Moore as senior scientific adviser to its biomedical arm.

Varian Halcyon treatment system receives Taiwan FDA approval.

Cancer Research Institute and Canadian Cancer Trials Group Announce Strategic Collaboration.

AGC Bioscience, Biomeva, and CMC Biologics to provide services under the brand AGC Biologics.

Illumina Launches iSeq 100 Sequencing System.

iGENE Laboratory granted licence by MOH to perform non-invasive prenatal test in Singapore.

Clarivate Analytics appoints new president for life sciences division.

Watsons partners with ChromaDex, to launch TRU NIAGEN in Singapore.

Colorcon, Inc. transforms sugar coating process with new Opadry System.

GSK Consumer Healthcare appoints Filippo Lanzi as head for Asia Pacific.

Chugai obtains approval for TECENTRIQ for treatment of unresectable, advanced or recurrent non-small cell lung cancer.

Historic deal signed between Panacea Biotec and Serum Institute of India.

me+ to partner Singapore Clinical Research Institute on new innovative healthcare solutions.

The following topics are under this section:

• ASIA-PACIFIC — Shedding Light on COVID-19 Vaccine Development
• ASIA-PACIFIC — Community-led Interventions for Improving Blood Pressure Control
• ASIA-PACIFIC — Importance of Redox Homeostasis in Potential Treatment of Disease
• ASIA-PACIFIC — Novel Processor Architecture to Solve Complex Mathematical Problems
• ASIA-PACIFIC — Uncovering Mechanisms of the Human Biological Clock
• ASIA-PACIFIC — Discovery of Healthy Stomach Stem Cells Reveals Cancer Origins
• ASIA-PACIFIC — Cataloguing Cancer “fingerprints” to Map Cancer Genomes
• ASIA-PACIFIC — Creating a Circular Economy using Greenhouse Gases
• REST OF THE WORLD — Guide for Liquid Biopsy in Individual Glioblastoma Patients
• REST OF THE WORLD — Multi-purpose use of Breast and Kidney Cancer Drugs
• REST OF THE WORLD — The Two Faces of Immune Cells
• REST OF THE WORLD — Fine Particle Air Pollution Linked to Development of Kidney Disease

For the month of December 2020, APBN features article contribution from variety of writers. In the Features we take a dive into how COVID-19 vaccines could be shipped worldwide in an article by Kawal Preet, President of Asia Pacific, Middle East and Africa (AMEA) region for FedEx. For the Columns section, explore the transformations in telehealth and telemedicine in the Asia Pacific region. Also, writers from ACT Genomics discuss how liquid biopsy could provide potential in replacing tissue biopsy in genomic alteration profiling. For this month in the Spotlights, are highlights from the recent APACMed Virtual Forum 2020 on how technology is changing the landscape of healthcare. Finally, Professor Nadey Hakim, a general surgeon and currently the vice president of the Royal Society of Medicine weighs in on the recent release of data on the study for Sputnik V vaccine against COVID-19.

For the month of March 2021, APBN takes a look at these aspects in our features section. We explore the potential use of loop-mediated isothermal amplification assay (LAMP) in molecular diagnostics in an article written by Mark Carascal, a scientist, science illustrator, and science communicator advocate. Also, in the Features section, we look at the rising prevalence of genetic disorders as well as gene editing technologies across the world in an article contribution by Saloni Walimbe. In our Columns section, we evaluate the sufficiency and feasibility of current policies in protecting patient health data and how there is room for improvement. Gain insight to how to improve healthcare access in a sustainable way in Thailand through closer collaboration between organizations. The Spotlights section for this month sheds light on a variety of topics, first we look at liquid biopsies as a cancer diagnostic tool in ensuring proper treatment in an interview with Dr Steven Olsen, CMO at Guardant Health AMEA. In another interview with Dr Agnes Siew Ling Tey, Senior Clinical Scientist, Nutrition R&D Centre for Asia Pacific, Abbott on the recent Phase Two findings from the SHIELD study on nutrition in the elderly. Finally, we share highlights from the ISPE Singapore Conference and Exhibition held in November 2020.